MinRes has copped a massive blow to its profit and won't pay a dividend as lithium, iron ore prices and additional capex hit.

The ASX took a hit as Trump’s tariff threat rattled markets, while NAB's earnings miss saw its stock tank, adding to the unease.

With underlying earnings growth of 7%, chemist owner and supplier EBOS Group is tapping healthy conditions in the sector.

Arca is trialling with BHP use of mining tailings to absorb greenhouse gases which could remove bulk carbon dioxide from the ...

As gold producer valuations soar, junior explorers are increasingly confident investor interest will head down the value ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

VHM has received significant federal government backing to support permitting of its Goschen mineral sands and rare earths ...

The Middle East healthcare sector is undergoing rapid expansion presenting opportunities for ASX-listed companies.

China's export controls on tungsten could mean higher prices for the commodity and healthy market conditions for ASX ...

Scammers are preying on cash-strapped Australians, promising a windfall but delivering financial ruin. Here’s how to protect ...

Blue Star Helium has spudded the Jackson 31 development well at its Galactica/Pegasus field that will be tied into production ...

While lithium-ion batteries continue to dominate energy storage, alternative battery technologies are starting to gain ...